Sort   by:  
 Page size 
UnknownFunctional Activity of Cytokine-Induced Killer Cells Enhanced by CAR-CD19 Modification or by Soluble Bispecific Antibody Blinatumomab.
Not available
S-EPMC11417890 | biostudies-literature
UnknownMutual epithelium-macrophage dependency in liver carcinogenesis mediated by ST18.
Not available
S-EPMC5412898 | biostudies-literature
UnknownEffect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet-Uro 19BEYOND study.
Not available
S-EPMC9385587 | biostudies-literature
UnknownA multicenter phase 2 single arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pre-treated with one immune-checkpoint inhibitor: The BREAKPOINT trial (Meet-Uro trial 03).
Not available
S-EPMC9896529 | biostudies-literature
UnknownSignificance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Not available
S-EPMC10918499 | biostudies-literature
Sort   by:  
 Page size